Influenza-like illness

News and Video Search Results

News coverage

HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1]

PR Newswire Asia 16 May 2024

· Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower..

Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
GlobeNewswire 07 May 2024
Generic Sterile Injectable Market Size to Worth USD 108.54 Bn by 2033
GlobeNewswire 03 May 2024
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
GlobeNewswire 18 Apr 2024
Invivyd Announces CEO Transition
GlobeNewswire 12 Apr 2024

0 shares 1 views

You might like

Influenza-like illness media coverage

Avian Influenza A(H5N1)"

Avian Influenza A(H5N1)"

Rumble 02 Apr 2024

Avian influenza A(H5N1) is a type of flu virus that usually infects wild birds and can spread to domestic birds and other animals...

Influenza Vaccine Equipment Market to Touch Valuation of USD 51.53 Billion by 2032, at 18.21% CAGR: Astute Analytica
GlobeNewswire 04 Apr 2024
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire 28 Mar 2024
ALO Collaborates with The Education University of Hong Kong
ACN Newswire 26 Mar 2024
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
GlobeNewswire 22 Mar 2024

Advertisement

More coverage

In Vitro Diagnostics Market Size Worth USD 128.33 Bn by 2033

GlobeNewswire 08 Mar 2024

The global in vitro diagnostics market size was valued at USD 107.77 billion in 2023 and is expected to be worth around USD 128.33..

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
GlobeNewswire 08 Mar 2024
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
GlobeNewswire 01 Mar 2024
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
GlobeNewswire 28 Feb 2024
Veterinary Molecular Diagnostics Market Set to Surge at 7.9 % CAGR, to Reach USD 1.1 billion by 2031 | Transparency Market Research, Inc.
GlobeNewswire 09 Feb 2024